Chirality (chemistry)In chemistry, a molecule or ion is called chiral (ˈkaɪrəl) if it cannot be superposed on its by any combination of rotations, translations, and some conformational changes. This geometric property is called chirality (kaɪˈrælɪti). The terms are derived from Ancient Greek χείρ (cheir) 'hand'; which is the canonical example of an object with this property. A chiral molecule or ion exists in two stereoisomers that are mirror images of each other, called enantiomers; they are often distinguished as either "right-handed" or "left-handed" by their absolute configuration or some other criterion.
Drug discoveryIn the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered by identifying the active ingredient from traditional remedies or by serendipitous discovery, as with penicillin. More recently, chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that had a desirable therapeutic effect in a process known as classical pharmacology.
Chiral anomalyIn theoretical physics, a chiral anomaly is the anomalous nonconservation of a chiral current. In everyday terms, it is equivalent to a sealed box that contained equal numbers of left and right-handed bolts, but when opened was found to have more left than right, or vice versa. Such events are expected to be prohibited according to classical conservation laws, but it is known there must be ways they can be broken, because we have evidence of charge–parity non-conservation ("CP violation").
Drug designDrug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it.
CP violationIn particle physics, CP violation is a violation of CP-symmetry (or charge conjugation parity symmetry): the combination of C-symmetry (charge symmetry) and P-symmetry (parity symmetry). CP-symmetry states that the laws of physics should be the same if a particle is interchanged with its antiparticle (C-symmetry) while its spatial coordinates are inverted ("mirror" or P-symmetry). The discovery of CP violation in 1964 in the decays of neutral kaons resulted in the Nobel Prize in Physics in 1980 for its discoverers James Cronin and Val Fitch.
StereocenterIn stereochemistry, a stereocenter of a molecule is an atom (center), axis or plane that is the focus of stereoisomerism; that is, when having at least three different groups bound to the stereocenter, interchanging any two different groups creates a new stereoisomer. Stereocenters are also referred to as stereogenic centers. A stereocenter is geometrically defined as a point (location) in a molecule; a stereocenter is usually but not always a specific atom, often carbon.
Chirality (physics)A chiral phenomenon is one that is not identical to its (see the article on mathematical chirality). The spin of a particle may be used to define a handedness, or helicity, for that particle, which, in the case of a massless particle, is the same as chirality. A symmetry transformation between the two is called parity transformation. Invariance under parity transformation by a Dirac fermion is called chiral symmetry. Helicity (particle physics) The helicity of a particle is positive (“right-handed”) if the direction of its spin is the same as the direction of its motion.
Fragment-based lead discoveryFragment-based lead discovery (FBLD) also known as fragment-based drug discovery (FBDD) is a method used for finding lead compounds as part of the drug discovery process. Fragments are small organic molecules which are small in size and low in molecular weight. It is based on identifying small chemical fragments, which may bind only weakly to the biological target, and then growing them or combining them to produce a lead with a higher affinity. FBLD can be compared with high-throughput screening (HTS).
ChiralityChirality kaɪˈrælɪtiː is a property of asymmetry important in several branches of science. The word chirality is derived from the Greek χειρ (kheir), "hand", a familiar chiral object. An object or a system is chiral if it is distinguishable from its ; that is, it cannot be superimposed onto it. Conversely, a mirror image of an achiral object, such as a sphere, cannot be distinguished from the object. A chiral object and its mirror image are called enantiomorphs (Greek, "opposite forms") or, when referring to molecules, enantiomers.
Flavour (particle physics)In particle physics, flavour or flavor refers to the species of an elementary particle. The Standard Model counts six flavours of quarks and six flavours of leptons. They are conventionally parameterized with flavour quantum numbers that are assigned to all subatomic particles. They can also be described by some of the family symmetries proposed for the quark-lepton generations. In classical mechanics, a force acting on a point-like particle can only alter the particle's dynamical state, i.e.
